Long-Term Efficacy, Safety, and Drug Survival of Guselkumab in Patients with Psoriasis: Real-World Data from the Czech Republic BIOREP Registry.

Jan HugoMartina KojanovaBarbora TurkovaSpyridon Gkalpakiotisnull null

Published in: Dermatology and therapy (2023)

This real-world study demonstrated the long-term effectiveness, good safety profile, and high drug survival of guselkumab treatment over a period of 36 months.

Keyphrases

randomized controlled trial
free survival
systematic review
electronic health record
adverse drug
big data
drug induced
emergency department
artificial intelligence
replacement therapy